Neochem Bio Solutions Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	841.73	611.46	481.88	494.98
Other Revenue	-0	1.14	-	0.74
Revenue	841.73	612.6	481.88	495.72
Revenue Growth (YoY)	37.40%	27.13%	-2.79%	-
Cost of Revenue	570.41	394.37	328.82	-
Gross Profit	271.32	218.24	153.07	495.72
Selling, General & Admin	95.08	83.44	78.52	472.23
Other Operating Expenses	27.54	65.39	26.96	-0
Operating Expenses	135.89	161.02	117.65	483.12
Operating Income	135.43	57.21	35.42	12.6
Interest Expense	-31.22	-25.12	-19.51	-
Interest & Investment Income	0.13	0.04	0.06	0.19
Currency Exchange Gain (Loss)	-	0.15	-	-
Other Non Operating Income (Expenses)	-2.47	-4.48	-0.78	0
EBT Excluding Unusual Items	101.87	27.8	15.18	12.79
Gain (Loss) on Sale of Assets	0.74	0.18	-	-
Pretax Income	102.61	27.98	15.18	12.79
Income Tax Expense	25.11	8.71	4.46	3.12
Net Income	77.51	19.27	10.73	9.67
Net Income to Common	77.51	19.27	10.73	9.67
Net Income Growth	302.21%	79.61%	10.91%	-
Shares Outstanding (Basic)	12	7	5	-
Shares Outstanding (Diluted)	12	7	5	-
Shares Change (YoY)	75.00%	26.16%	-	-
EPS (Basic)	6.64	2.89	2.03	-
EPS (Diluted)	6.64	2.89	2.03	-
EPS Growth	129.83%	42.36%	-	-
Free Cash Flow	14.54	-90.16	-40.72	-
Free Cash Flow Per Share	1.24	-13.51	-7.70	-
Gross Margin	32.23%	35.63%	31.76%	100.00%
Operating Margin	16.09%	9.34%	7.35%	2.54%
Profit Margin	9.21%	3.15%	2.23%	1.95%
Free Cash Flow Margin	1.73%	-14.72%	-8.45%	-
EBITDA	148.71	69.41	47.59	23.49
EBITDA Margin	17.67%	11.33%	9.88%	4.74%
D&A For EBITDA	13.28	12.2	12.17	10.89
EBIT	135.43	57.21	35.42	12.6
EBIT Margin	16.09%	9.34%	7.35%	2.54%
Effective Tax Rate	24.47%	31.13%	29.34%	24.39%
Revenue as Reported	861.54	620.08	487.9	495.91
Advertising Expenses	8.27	-	10.38	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.